Journal
EXPERT REVIEW OF CLINICAL IMMUNOLOGY
Volume 12, Issue 11, Pages 1191-1208Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/1744666X.2016.1196135
Keywords
Sarcoidosis; biomarkers; angiotensin converting enzyme; diagnosis; prognosis
Categories
Ask authors/readers for more resources
Introduction: Numerous biomarkers have been evaluated for the diagnosis, assessment of disease activity, prognosis, and response to treatment in sarcoidosis. In this report, we discuss the clinical and research utility of several biomarkers used to evaluate sarcoidosis.Areas covered: The sarcoidosis biomarkers discussed include serologic tests, imaging studies, identification of inflammatory cells and genetic analyses. Literature was obtained from medical databases including PubMed and Web of Science.Expert commentary: Most of the biomarkers examined in sarcoidosis are not adequately specific or sensitive to be used in isolation to make clinical decisions. However, several sarcoidosis biomarkers have an important role in the clinical management of sarcoidosis when they are coupled with clinical data including the results of other biomarkers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available